Participation of the nitric oxide-cyclic GMP-ATP-sensitive K + channel pathway in the antinociceptive action of ketorolac

By Lazaro-Ibanez G.G.   Torres-Lopez J.E.   Granados-Soto V.  

European Journal of Pharmacology, Vol. 426, Iss. 1, 2001-08 ,pp. : 39-44

Elsevier

Access to resources Recommend Favorite

Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test

By Granados-Soto V.   Rufino M.d.O.   Gomes Lopes L.D.   Ferreira S.H.  

European Journal of Pharmacology, Vol. 340, Iss. 2, 1997-12 ,pp. : 177-180

Elsevier

Access to resources Recommend Favorite

Modulation of glutamate release by a nitric oxide/cyclic GMP-dependent pathway

By Sistiaga A.   Miras-Portugal M.T.   Sanchez-Prieto J.  

European Journal of Pharmacology, Vol. 321, Iss. 2, 1997-02 ,pp. : 247-257

Elsevier

Access to resources Recommend Favorite

Peripheral and central activation of nitric oxide–cyclic GMP pathway by sildenafil

By Patil Chandrashekhar S.   Singh Vijay Pal   Kulkarni Shrinivas K.  

Inflammopharmacology, Vol. 13, Iss. 5-6, 2005-10 ,pp. : 467-478

VSP

Access to resources Recommend Favorite

The -opioid agonist (+/-)-bremazocine elicits peripheral antinociception by activation of the l-arginine/nitric oxide/cyclic GMP pathway

By Amarante L.H.   Duarte I.D.G.  

European Journal of Pharmacology, Vol. 454, Iss. 1, 2002-11 ,pp. : 19-23

Elsevier

Access to resources Recommend Favorite